IL1B and periodontal disorder: Both diabetes and periodontal disease involve elevated levels of inflammatory mediators such as interleukin-1β (IL-1β); tumour necrosis factor-α (TNFα), accumulation of reactive oxygen species (ROS) and advanced glycation end products (AGEs) [35].